File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Portrait of PTEN: Messages from mutant mice

TitlePortrait of PTEN: Messages from mutant mice
Authors
Issue Date2008
Citation
Cancer Science, 2008, v. 99, n. 2, p. 209-213 How to Cite?
AbstractPTEN is a tumor suppressor gene mutated in many human sporadic cancers and in hereditary cancer syndromes such as Cowden disease. The major substrate of PTEN is phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3), a second messenger molecule produced following PI3K activation induced by a variety of stimuli. PI(3,4,5)P3 activates the serine-threonine kinase Akt, which is involved in antiapoptosis, proliferation and oncogenesis. In mice, heterozygosity for a null mutation of Pten (Pten-/- mice) frequently leads to the development of a variety of cancers and autoimmune disease. Homozygosity for the null mutation (Pten-/- mice) results in early embryonic lethality, precluding the functional analysis of Pten in adult tissues and organs. To investigate the physiological functions of Pten in viable mice, we and other groups have used the Cre-loxP system to generate various tissue-specific Pten mutations. The present review will summarize results obtained from the study of conditional mutant mice lacking Pten in specific tissues, and discuss the possible biological and molecular explanations for why Pten deficiency leads to tumorigenesis. © 2007 Japanese Cancer Association.
Persistent Identifierhttp://hdl.handle.net/10722/291809
ISSN
2023 Impact Factor: 4.5
2023 SCImago Journal Rankings: 1.625
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSuzuki, Akira-
dc.contributor.authorNakano, Toru-
dc.contributor.authorMak, Tak Wah-
dc.contributor.authorSasaki, Takehiko-
dc.date.accessioned2020-11-17T14:55:10Z-
dc.date.available2020-11-17T14:55:10Z-
dc.date.issued2008-
dc.identifier.citationCancer Science, 2008, v. 99, n. 2, p. 209-213-
dc.identifier.issn1347-9032-
dc.identifier.urihttp://hdl.handle.net/10722/291809-
dc.description.abstractPTEN is a tumor suppressor gene mutated in many human sporadic cancers and in hereditary cancer syndromes such as Cowden disease. The major substrate of PTEN is phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3), a second messenger molecule produced following PI3K activation induced by a variety of stimuli. PI(3,4,5)P3 activates the serine-threonine kinase Akt, which is involved in antiapoptosis, proliferation and oncogenesis. In mice, heterozygosity for a null mutation of Pten (Pten-/- mice) frequently leads to the development of a variety of cancers and autoimmune disease. Homozygosity for the null mutation (Pten-/- mice) results in early embryonic lethality, precluding the functional analysis of Pten in adult tissues and organs. To investigate the physiological functions of Pten in viable mice, we and other groups have used the Cre-loxP system to generate various tissue-specific Pten mutations. The present review will summarize results obtained from the study of conditional mutant mice lacking Pten in specific tissues, and discuss the possible biological and molecular explanations for why Pten deficiency leads to tumorigenesis. © 2007 Japanese Cancer Association.-
dc.languageeng-
dc.relation.ispartofCancer Science-
dc.titlePortrait of PTEN: Messages from mutant mice-
dc.typeArticle-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1111/j.1349-7006.2007.00670.x-
dc.identifier.pmid18201277-
dc.identifier.scopuseid_2-s2.0-39049101676-
dc.identifier.volume99-
dc.identifier.issue2-
dc.identifier.spage209-
dc.identifier.epage213-
dc.identifier.eissn1349-7006-
dc.identifier.isiWOS:000252966800004-
dc.identifier.issnl1347-9032-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats